Innovations in Drug Pricing and Reimbursement (2016)
|藥價及給付的革新:保險者的展望 (2016年) Innovations in Drug Pricing and Reimbursement (2016)|
|出版日期: 2016年02月01日||內容資訊: 英文||
The pharma industry is winning few friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty medicines and even generics grow excessively. How are payers in the US and Europe responding and what cost containment strategies are being - and could be - employed to cap rampant and increasingly unaffordable drug bills?
Drug Pricing: Health payers gear up for battle is ahard-hitting reportwhich reveals what US and European health payers are really thinking and planning. Often blunt, and always incisive, this report contains valuable and clear lessons for industry - and lessons they should learn well.
“It's pretty discouraging, unfortunately. It makes you think these companies are not really involved in healthcare. I don't think they are...They just are profit centres.” US Payer.
The report is informed through in-depth interviews with payers responsible for drug budgets in the US and EU5 leading economies. To ensure open and critical responses all contributors are anonymous but include: